Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
about
Chimeric antigen receptor T cells: a novel therapy for solid tumors.CAR-T cell therapy in ovarian cancer: from the bench to the bedside.Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
P2860
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Development of T cells carryin ...... t of hepatocellular carcinoma.
@en
Development of T cells carryin ...... t of hepatocellular carcinoma.
@nl
type
label
Development of T cells carryin ...... t of hepatocellular carcinoma.
@en
Development of T cells carryin ...... t of hepatocellular carcinoma.
@nl
prefLabel
Development of T cells carryin ...... t of hepatocellular carcinoma.
@en
Development of T cells carryin ...... t of hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Development of T cells carryin ...... t of hepatocellular carcinoma.
@en
P2093
Cheng Chen
Hongyang Wang
Huamao Wang
Huiping Gao
Xiaorong Pan
P2860
P2888
P304
P356
10.1007/S00262-016-1949-8
P577
2016-12-29T00:00:00Z